Dan Huh

Vivodyne, Inc. is a biotechnology company based in Philadelphia, PA. Vivodyne accelerates the development of more effective medicines by testing on thousands of lifelike, lab-grown human organ tissues at a time. The company uses robots to grow and experiment on lab-grown human organs at a massive scale, creating datasets of unparalleled realism and breadth to power a predictive AI platform technology. Vivodyne's platform powers the entire discovery pipeline by testing drugs on thousands of lab-grown human tissues with complete robotic automation, accelerating the discovery of cures to human diseases by creating predictive, preclinical human data. The company was founded by Andrei Georgescu and Dan Huh, with Andrei Georgescu serving as the CEO since incorporation.

Vivodyne, Inc. is a biotechnology company based in Philadelphia, PA. Vivodyne accelerates the development of more effective medicines by testing on thousands of lifelike, lab-grown human organ tissues at a time. The company uses robots to grow and experiment on lab-grown human organs at a massive scale, creating datasets of unparalleled realism and breadth to power a predictive AI platform technology. Vivodyne's platform powers the entire discovery pipeline by testing drugs on thousands of lab-grown human tissues with complete robotic automation, accelerating the discovery of cures to human diseases by creating predictive, preclinical human data. The company was founded by Andrei Georgescu and Dan Huh, with Andrei Georgescu serving as the CEO since incorporation.

Vivodyne, Inc. is a biotechnology company based in Philadelphia, PA. Vivodyne accelerates the development of more effective medicines by testing on thousands of lifelike, lab-grown human organ tissues at a time. The company uses robots to grow and experiment on lab-grown human organs at a massive scale, creating datasets of unparalleled realism and breadth to power a predictive AI platform technology. Vivodyne's platform powers the entire discovery pipeline by testing drugs on thousands of lab-grown human tissues with complete robotic automation, accelerating the discovery of cures to human diseases by creating predictive, preclinical human data. The company was founded by Andrei Georgescu and Dan Huh, with Andrei Georgescu serving as the CEO since incorporation.